Financial Partners Group (Kansas)’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Financial Partners Group (Kansas)’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$373K	Buy	3,765 +34	+0.9%	+$3.06K	0.04%	177
2026 Q1	$323K	Sell	3,731 -22	-0.6%	-$1.93K	0.04%	172
2025 Q4	$325K	Buy	+3,753	New	+$300K	0.04%	175
2018 Q3	–	Sell	-42,426	Closed	-$2.14M	–	79
2018 Q2	$2.14M	Sell	42,426 -399	-0.9%	-$19.8K	1.57%	19
2018 Q1	$2.11M	Sell	42,825 -12,816	-23%	-$658K	1.65%	21
2017 Q4	$2.86M	Buy	+55,641	New	+$2.86M	2.26%	15

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Financial Partners Group (Kansas)'s IHE Position: Q2 2026 in Review

Financial Partners Group (Kansas) increased its iShares US Pharmaceuticals ETF (IHE) stake by 0.91% in Q2 2026, buying an estimated $3.06K and bringing the position to 3,765 shares worth $373K. The position accounts for 0.04% of the portfolio, ranked #177.

Financial Partners Group (Kansas) first reported a position in IHE in Q4 2017 and has held it in 6 quarters since. The position peaked at $2.86M in Q4 2017. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Financial Partners Group (Kansas) held 3,765 shares of iShares US Pharmaceuticals ETF worth $373K as of Q2 2026.
Financial Partners Group (Kansas) bought 34 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $3.06K.
iShares US Pharmaceuticals ETF made up 0.04% of Financial Partners Group (Kansas)'s portfolio in Q2 2026, its #177 holding.
Financial Partners Group (Kansas) first reported a position in iShares US Pharmaceuticals ETF in Q4 2017 and has held it in 6 quarters since.
Financial Partners Group (Kansas)'s iShares US Pharmaceuticals ETF position peaked at $2.86M in Q4 2017.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Financial Partners Group (Kansas)'s 13F filing for Q2 2026, filed 23 Jul 2026.